SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Applied Digital Corporation

Applied Digital is experiencing intense volatility as investors weigh the stock's long-term potential in AI infrastructure against macro-driven sell-offs linked to geopolitical tensions and debt concerns. The community remains divided between those panic-selling and those adding to their positions, with sentiment heavily focused on the anticipation of new hyperscaler lease announcements serving as a major catalyst for a price recovery.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is experiencing significant volatility and a brutal sell-off as broader market concerns over geopolitical instability and shifting semiconductor sector sentiment weigh on the stock. While some investors argue that the pullback is an overreaction to artificial demand concerns and see it as a buying opportunity, others are actively discussing the impact of cyclical memory pricing and the risk of further downside if the current market rotation continues.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is currently experiencing intense market volatility as investors weigh the stock's long-term potential in AI infrastructure against concerns over share dilution and the absence of imminent deal announcements. While community sentiment remains split between long-term bulls accumulating on dips and frustrated traders reacting to broader sector sell-offs, the stock continues to be a focal point for intense technical speculation and high-volume options activity.

MP Materials Corp. engages in the production and marketing of rare earth specialty materials. It operates through the Materials and Magnetics segments. The Materials segment focuses on the operation of Mountain Pass, which produces refined rare earth oxides and related products, as well as rare earth concentrate products. The Magnetics segment is involved in the operation of Independence Facility, where the company began production of magnetic precursor products. The company was founded by James Henry Litinsky and Michael Rosenthal in 2017 and is headquartered in Las Vegas, NV.

MP Materials Corporation

MP Materials is trending as investors weigh strong long-term vertical integration milestones and government-backed price supports against short-term volatility and concerns over production scale-up. The community is actively debating the stock's future, with many focusing on the potential for domestic supply chain dominance in rare earth magnets while others express frustration over recent price fluctuations and negative sentiment driven by bot-related activity.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending due to the completion of Phase 3 enrollment for its lead obesity asset, VK2735, which has fueled excitement about its potential to compete with major GLP-1 incumbents. The community is actively debating the stock's future, balancing intense discussions about a potential buyout against concerns regarding clinical trial timelines, market competition, and the impact of broader macroeconomic volatility.

Federal National Mortgage Association is a government-sponsored company, which engages in the provision of liquidity for purchases of homes and financing of multifamily rental housing and refinancing existing mortgages. It operates through the Single-Family and Multifamily segments. The Single-Family segment offers liquidity to the mortgage market and increases the availability and affordability of housing for single families. The Multifamily segment includes guaranty fees on mortgages and on multifamily mortgage loans. The company was founded in 1938 and is headquartered in Washington, DC.

Federal National Mortgage Association

Fannie Mae (FNMA) is experiencing heightened volatility and intense community discussion following Bill Ackmans public endorsement of the stock as an asymmetric opportunity with significant upside potential. While some investors are viewing recent price action as a strategic loading phase driven by the prospect of a government exit from conservatorship, others remain skeptical due to political uncertainty and the lack of a clear, immediate timeline for institutional reform.

Maul Coin

Maul Coin is gaining significant traction as investors rally around its potential as a grassroots movement, with the community actively coordinating to sustain momentum and overcome whale sell pressure. Enthusiasts are drawing comparisons to other high-growth meme coins, focusing on collective holding strategies to increase market visibility and drive project adoption.

Cipher Digital, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Digital Inc.

Cipher Mining Inc

Cipher Mining is facing downward pressure amid a broad risk-off sentiment in the data center and AI infrastructure sector, leaving investors to debate whether this is a temporary volatility shakeout or a deeper correction. Despite recent operational expansion and hyperscale lease activity, the community is actively tracking institutional selling and broader market technicals to determine if the stock is a buying opportunity or a deeper value trap.

Pelican Acquisition Corporation is a special-purpose acquisition company that aims to merge with or acquire businesses, particularly in the global technology sector. The company's primary purpose of facilitate a merger, share exchange, asset acquisition, share purchase, reorganization, or any other form of business combination with one or more businesses.

Greenland Energy Co.

Greenland Energy (GLND) is trending as traders debate its potential as a low-float energy play following a recent business combination and news regarding strategic Arctic drilling agreements. While some community members highlight the massive unrisked oil potential in the Jameson Land Basin and the involvement of experienced industry leadership, others remain skeptical, warning of high volatility and the risks associated with early-stage resource exploration.

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Boston Scientific Corp.

Boston Scientific is currently trending as investors weigh strong cardiovascular growth and recent acquisitions against short-term dilution concerns and a volatile price action. The community is actively debating whether the stock's recent pullback presents a long-term value opportunity or a sign of deeper structural weakness, with many tracking analyst upgrades and the potential for a rebound driven by a robust pipeline of minimally invasive medical technologies.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$LXRXI used to think Dr. Bhatt is on our side commercially, not any more. His interests in Sota are only academic - publishing papers to boost his scholarly standing. What we know about him other than his numerous titles:

- He served as the PI for almost all Sota&#39;s early clinical trials,
- He is a sitting board member of BMY,
- He was the first in his paper suggesting MI and stroke benefits due to SGLT1i, but cautioned for additional clinical trial,
- He should know better than anybody on this planet that Sota&#39;s potency in preventing HHF or CVD death is leading the pack of SGLT inhibitor class of drugs.

He should know that Sota could have saved Medicare $B&#39;s in HHF (4-in-1 vs. 20-in-1). As one of the most influential figures in the field of Cardiology, he did nothing other than pushing academic papers.

After 10 years of following him, I think he put his own interests way ahead of public ones, which is nothing wrong - just purely a personal choice, that&#39;s all!

$LXRX Tomorrow is the last day of the Annual American College of Cardiology. 
🏛️ The &quot;Super Bowl&quot; of Cardiology
The American College of Cardiology (ACC) isn&#39;t just a &quot;medical meeting&quot;—it’s the supreme court of heart health. For over 75 years, this is where the &quot;Standard of Care&quot; is written. Think back to the trials that gave us TAVR and Entresto; those lines in the sand were drawn right here.
🎸 The Rockstar Factor: Dr. Deepak Bhatt
When Dr. Deepak Bhatt takes the podium for Lexicon, it’s like having a Hall of Famer give a keynote. He is one of the most cited researchers in history. When he presents data on sotagliflozin, the entire medical community stops and takes notes. His involvement is a massive &quot;stamp of authenticity&quot; that institutional investors crave. 📈

StockTwits for iOS

Lexicon Pharmaceuticals Inc

nomada

StockTwits For Android 

Wyane

Barrick Mining Corp

$LXRXI used to think Dr. Bhatt is on our side commercially, not any more. His interests in Sota are only academic - publishing papers to boost his scholarly standing. What we know about him other than his numerous titles:

- He served as the PI for almost all Sota's early clinical trials,
- He is a sitting board member of BMY,
- He was the first in his paper suggesting MI and stroke benefits due to SGLT1i, but cautioned for additional clinical trial,
- He should know better than anybody on this planet that Sota's potency in preventing HHF or CVD death is leading the pack of SGLT inhibitor class of drugs.

He should know that Sota could have saved Medicare 

's in HHF (4-in-1 vs. 20-in-1). As one of the most influential figures in the field of Cardiology, he did nothing other than pushing academic papers.

After 10 years of following him, I think he put his own interests way ahead of public ones, which is nothing wrong - just purely a personal choice, that's all!